:

VARDA EXPANDS SPACE DRUG MANUFACTURING AFTER HIV SUCCESS

AI DESK1 MIN READ
WED, MAY 13, 2026

■ AI-SUMMARIZED FROM 1 SOURCE ▸ TIMELINE

Varda Space Industries is scaling up its orbital pharmaceutical operations following successful crystallization of HIV medication Ritonavir in space. CEO Will Bruey announced plans to broaden the company's drug manufacturing beyond this initial achievement.

Varda's recent win with Ritonavir marks a validation of its core business model: manufacturing pharmaceuticals in microgravity environments where different crystalline structures can form compared to Earth-based production. The unique properties of space-grown crystals could improve drug efficacy or bioavailability for certain medications. The company plans to leverage this proof-of-concept to develop additional drugs for orbital production. Varda operates in-space manufacturing spacecraft designed to return crystallized compounds to Earth for further development and commercialization. This expansion reflects growing investor interest in space-based manufacturing. Companies increasingly view microgravity as a viable production environment for high-value pharmaceuticals where Earth-based constraints limit results. Varda joins a small cohort of firms exploring orbital manufacturing, though most remain in early-stage development. The company's successful Ritonavir crystallization demonstration positions it as a near-term leader in commercializing this emerging sector.

■ SOURCES

Bloomberg Tech

■ SUMMARY WRITTEN BY AI FROM THE LINKS ABOVE

■ MORE FROM THE STARTUPS DESK

Town, an enterprise personal AI assistant platform, is in talks to raise funding at a $1 billion valuation in a round led by Index Ventures, according to sources.

YESTERDAYAI Desk

Product management platform Linear reached $100M in annual recurring revenue and conducted a $99M employee tender offer at a $2.5B valuation, doubling its valuation from $1.25B in 2025.

AUG 26Industry Desk

Flipboard is acquiring Bluesky feed-building startup Graze, integrating its ad technology and creator monetization tools into its open social web platform.

AUG 26Industry Desk

Artificial intelligence is fundamentally changing how startups operate, not just what they build. According to Floodgate co-founder Ann Miura-Ko, companies are deploying AI agents across engineering, sales, marketing, and strategy to accelerate learning and execution.

AUG 26AI Desk

■ SUBSCRIBE TO THE DAILY BRIEF

ONE EMAIL, 5 STORIES, 06:00 UTC. UNSUBSCRIBE ANYTIME.